This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

First Case In VISIUS Surgical Theatre At Florida Hospital

Intraoperative Imaging System at the Heart of New Neurosurgical Suite

WINNIPEG, Jan. 31, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported on the first neurosurgical case that was performed in the new VISIUS Surgical Theatre at Florida Hospital in Orlando, Fla. Dr. Melvin Field, Director of the Florida Hospital Minimally Invasive Brain Surgery Program and Surgical Director of the Florida Hospital Neuroscience Institute, performed the case on December 19, 2011 involving a resection of a pituitary tumor in an adult patient. The intraoperative MR images taken before completing the procedure confirmed that the entire tumor had been removed as planned. Afterwards, Dr. Field commented: "While we have been able to treat these tumors before, the intraoperative technology allowed us to confirm that we had fully removed the entire tumor before ending surgery, eliminating the need for post-operative repeat imaging or reoperation." He continued: "We were also able to inform the patient's family of the surgery's complete success before they even went in to see him."

"Getting it all out" is a primary patient concern when it comes to brain tumor treatment.  According to research at the University of California in San Francisco in 2007, improved outcomes among adult patients with certain kinds of aggressive tumors is predicted by greater extent of resection.  A study published by Barnes-Jewish Hospital in 2011 showed that using intraoperative MR imaging during tumor resection, surgeons achieved gross total resection in 93% of their patients, compared to achieving gross total resection in only 65% of their patients when intraoperative MR was not used.

Located within Florida Hospital Orlando's new 35,000 square-foot neurosurgery center, the VISIUS Surgical Theatre features two state-of-the-art operating rooms connected by a room used for diagnostic imaging and a ceiling-mounted MR scanner that moves between all three rooms.  The larger of the two ORs, called InnovatOR, is a surgical center in which clinical staff and industry partners will co-develop products, techniques and processes to improve patient outcomes and increase clinician efficiency.  Unique to the VISIUS Surgical Theatre is the first removable MR-compatible operating table, which can be completely removed from the operating room to allow surgeons to perform procedures that require a specific surgical table.

Eric Stevens, Vice President of Operations at Florida Hospital Orlando, comments: "Our initial success is very encouraging.  The intraoperative imaging capability of the VISIUS Surgical Theatre is central to our strategy to improve patient outcomes in neurosurgery by combining innovative technologies and partnering with medical industry leaders like IMRIS."

About Florida Hospital Neuroscience Institute

The Florida Hospital Neuroscience Institute (NSI) treats more neurology patients than any other hospital in the nation and features the largest neurosurgery program in Florida. As leader in brain and spine disorders, NSI includes more than 80 physicians providing multidisciplinary care through comprehensive programs in neurosurgery, interventional neuroradiology, neuro-oncology, neurodiagnostics and stroke and spine centers


IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs